Mrs. Diane W. Kecskes, MD

Recommended Articles

• Alzheimer's Breakthrough: Study Has Found a Change in Protein Can Reverse Alzheimer's Damage

  Alzheimer’s is a progressive brain disorder that has no cure. When a person develops the disease, they develop amyloid plaques as well as neurofibrillary tangles. As the condition worsens, the neurons deteriorate, eventually dying out.Both early and late onset Alzheimer's disease have a genetic...

• President Trump Is Urged to "Make a Deal" to Aid Multiple Sclerosis Patients

  ...

• What Is Euthymia?

  IntroductionA person is often regarded as when in the longitudinal course of mood disturbances, the threshold of a disorder is not met. People with bipolar disorder may spend most of their time in the state of mania, depression, or in a mixed state, while the rest are in euthymia. Certain...

• What is the Difference Between Alzheimer's Disease and Dementia?

  Dementia is a brain disorder that affects communication and causes difficulty in performing daily tasks. Alzheimer’s disease, on the other hand, affects the parts of the brain that control language, thought, and memory, and it is a specific form of dementia.Though dementia and Alzheimer’s...

• What is Apraxia?

  Apraxia is a neurological condition in which the affected person may not be able to perform a particular movement when they want to. This is true even when the movement is learned. In some cases, mild symptoms are seen and this condition is referred to as dyspraxia. There are different types of...

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...